March 26, 2020 / 7:11 AM / 13 days ago

BRIEF-Saniona Enters Second Collaboration Agreement With Boehringer Ingelheim

March 26 (Reuters) - Saniona AB:

* REG-SANIONA ENTERS INTO SECOND COLLABORATION AGREEMENT WITH BOEHRINGER INGELHEIM IN SCHIZOPHRENIA

* MAY RECEIVE UP TO EUR 76.5 MILLION IN MILESTONES PLUS ROYALTIES ON WORLDWIDE NET SALES

* FIRST SCHIZOPHRENIA PROGRAM WITH BOEHRINGER INGELHEIM IS IN PRECLINICAL STAGE

* OBJECTIVE IS TO IDENTIFY NEW TREATMENT OPTIONS FOR SCHIZOPHRENIA, BY EXPLORING A NOVEL UNDISCLOSED CNS ION CHANNEL TARGET

* WILL RECEIVE RESEARCH FUNDING DURING JOINT RESEARCH PERIOD.

* DURING FIRST YEAR OF COLLABORATION, SANIONA EXPECTS TO RECEIVE RESEARCH FUNDING OF AROUND SEK 5 MILLION Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below